A Ernest Toth Jr insider trades: Aquestive Therapeutics (AQST) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where A reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | AQST | ↓ Sell | 58,254 | $4.17 | $243K | Direct | Mar 11, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AQST insiders
Open-market trades in the last 12 months
About A Ernest Toth Jr's insider trades
A Ernest Toth Jr is Chief Financial Officer at Aquestive Therapeutics (AQST). Since Mar 10, 2026, A has reported no open-market purchases and 1 sale worth $243K on SEC Form 4. In the last 12 months: 1 sale ($243K).
Their filings also include grants and awards (12 filings), shares withheld for taxes (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AQST insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.